Socialstyrelsen establishes SweCan to coordinate cancer innovation

The Danish Association of the Pharmaceutical Industry (LIF) warns: medicines will come later to Europe and Denmark

Sweden’s regions broaden use of tripartite negotiations

Reimbursement can change even when the medicines do not – KELA revise reimbursement status for severe mental health disorders

NICE sets a dedicated fertility pathway for endometriosis

NICE and MHRA align reviews to speed access

Lif CEO Sofia Wallström urges focus on timely access in pharma inquiry

TLV updates government on US pricing policy monitoring

Lif chair re-elected amid focus on alignment

Denmark consults on reimbursement status for cancer medicines